Atlas Trials

Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Liver Cancer

Clinical trial NCT03484962 · WITHDRAWN

Trial details

NCT number
NCT03484962
Sponsor
Fuda Cancer Hospital, Guangzhou
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Advanced Liver Cancer
Start date
2018-03-25
Primary completion
2020-05-25
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.